Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

182 trials

NCT07818772
Recruiting
7T Imaging Pilot-study in Patients With Motor Neuron Disease to Find Non-Invasive Disease Imaging Biomarkers
Not applicable · United Kingdom · 1 site
Registry update: 14 Sept 2026
NCT07467187
Recruiting
Invasive Home Ventilation in Denmark
Not applicable · Denmark · 1 site
Registry update: 20 Apr 2026
NCT07187388
Recruiting
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
Not applicable · United States · 1 site
Registry update: 27 May 2026
NCT07357428
Recruiting
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Not applicable · United States · 3 sites
Registry update: 14 Apr 2026
NCT07502677
Recruiting
Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis
Not applicable · United Kingdom · 1 site
Registry update: 31 Mar 2026
NCT07369076
Recruiting
A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.
Phase 1/2 · Australia, Canada, Netherlands, Poland · 12 sites
Registry update: 17 Sept 2026
NCT05936619
Recruiting
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
Not applicable · United States · 1 site
Registry update: 30 Oct 2026
2024-513927-18-00
Recruiting
A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in participants with Amyotrophic Lateral Sclerosis
Phase 2 · Norway · 14 sites
Registry update: 24 Jun 2026
NCT07509125
Recruiting
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
Not applicable · Belgium · 1 site
Registry update: 3 Apr 2026
NCT07204977
Recruiting
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
Phase 1 · United States · 1 site
Registry update: 1 Oct 2026
NCT07322003
Recruiting
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Phase 3 · Belgium, Canada, Germany, Spain, France, United Kingdom, Ireland, Israel, Italy, Netherlands, Poland, Sweden, United States · 56 sites
Registry update: 27 Oct 2026
NCT07017946
Recruiting
Intestinal Microbiome Transplant in ALS
Phase 1/2 · United States · 1 site
Registry update: 8 Jul 2026
NCT07233148
Recruiting
Healing ALS Registry Observational Study (HAROS)
Not applicable · United States · 1 site
Registry update: 24 Jun 2026
NCT07091799
Recruiting
Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS
Not applicable · France · 1 site
Registry update: 21 Jan 2026
NCT07401121
Recruiting
Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis
Phase 1 · Australia · 1 site
Registry update: 10 Feb 2026
NCT07290062
Recruiting
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Phase 1 · United States · 7 sites
Registry update: 23 Sept 2026
NCT07407725
Recruiting
Clinical Outcome Assessment for AT & BCI
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07259980
Recruiting
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
Not applicable · United States · 1 site
Registry update: 9 Apr 2026
NCT07294144
Recruiting
Tofersen in Non-SOD1 ALS
Phase 2 · United States · 3 sites
Registry update: 25 Jun 2026
NCT07287397
Recruiting
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Phase 1/2 · Belgium, Spain, United Kingdom, Netherlands, United States · 11 sites
Registry update: 6 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.